Stereotactic Body Radiotherapy (SBRT)
Stereotactic Body Radiotherapy (SBRT) is a radiation therapy with 68 clinical trials. Currently 25 active trials ongoing. Historical success rate of 61.5%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
21
Early Stage
18
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
59.3%
16 of 27 finished
40.7%
11 ended early
25
trials recruiting
68
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
Clinical Trials (68)
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
Stereotactic PAncreatic RadioTherapy Adjuvant Therapy
FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location
Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating
Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
SBRT Versus Surgical Resection for Small HCC
Span-C-SBRT for Pancreatic Cancer
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 68